dr Patrick soon shiong

dr Patrick soon shiong Chairman of chan soon-shiong family foundation, Exec chairman immunitybio, chairman and chief Executive los Angeles times media group (LATMG)

Great announcement today by HHS and NCI to support cancer vaccine trials. We have spent the past decade collaborating wi...
03/20/2026

Great announcement today by HHS and NCI to support cancer vaccine trials. We have spent the past decade collaborating with 2 amazing thought leaders at the National Cancer Institute (NCI) in the field of cancer vaccine, Dr James Gulley and Dr Jeffrey Schlom.

Together we have completed Phase 1 & 2 trials across multiple tumor types showing how our Adeno vaccine plus Anktiva generates tumor specific T cells. The randomized trial to PREVENT cancer in subjects with Lynch Syndrome which affects over a million Americans (1 in 278) is fully enrolled and the early data so far shows that Anktiva and the Adeno vaccine increases NK and T cells in these subjects, even in subjects aged 65

03/20/2026

So exciting to see the results of Anktiva in bladder cancer in women who tend to have higher-grade and more advanced tumors, resulting in a higher risk of recurrence and lower survival rates compared to men.

Grateful for Deborah allowing us to tell her story of papillary disease that then recurs to CIS with BCG alone... and now in complete remission after Anktiva + BCG. Further evidence that papillary and CIS disease are clonally the same.

03/20/2026

We have now initiated the process of establishing the WORLD BANK OF NATURAL KILLER CELLS and identified global cancer centers where our robots will be installed.

Imagine if this can now be automated so that TRILLIONS OF NK cells can be stored and even engineered as CAR-NK cell therapy for the entire globe as off-the-shelf therapy with Anktiva! Its here.

The AI driven manufacturing robot (Leonardo) has been trained with our software and more news to come soon on that... the world of memory cytokine enhanced NK cells or M-ceNK for short.

03/20/2026

My meeting with and HRH MBS in May 2025 resulted in such amazing results and action!

In less than a year we received the world’s first approval for lung cancer for the Bioshield… and now we have established a wholly owned subsidiary in the Kingdom to support physicians and healthcare systems throughout the MENA region.

Distribution readiness of Anktiva for both bladder and lung cancer patients since approval just one year ago will amaze all at the speed… congratulations to our team who worked tirelessly to make this happen and ensure rapid access of the Bioshield to patients in the Kingdom... stay tuned!

03/20/2026

Just received amazingly exciting analysis of the first 20 subjects without cancer but with Lynch Syndrome ( now fully enrolled with 138 randomized to either Anktiva plus our Adeno CANCER VACCINE versus placebo). This first set of biological immune data from NCI ( Dr Jeff Schlom) and his team is so exciting and confirms the immune stimulating effect of Anktiva re ALC. Also it shows that as we age the baseline ALC is low but Anktiva changes that level..really exciting especially in light of the JAMA paper that shows 1 in 5 Americans suffer from lymphopenia and that with a low ALC this results in a significant lower lifespan. More to come! The cancer vaccine trials are underway!

03/20/2026

Here is the exciting world of AI. My presentation of the cancer mind map after a decade of work to prove the hypothesis that empowering the innate and adaptive immune system could cure cancer.

So I dictated some of my talk to an AI platform and became the "source" that is mentioned in this audio... amazingly, it took my mind map and created this conversation! Take a listen, it explains beautifully how we think about attacking cancer.

Evidence as far back as a decade ago that the tumor itself shape shifts in response to chemo! We need to anticipate thes...
03/20/2026

Evidence as far back as a decade ago that the tumor itself shape shifts in response to chemo! We need to anticipate these moves ahead of time to counter them... chess instead of checkers. That's the paradigm change of Quantum Oncotherapeutics and Immunotherapy 2.0

nature.com/articles/ncomm…

03/20/2026

Jim Allison's conversation about treating the immune system and not the cancer and why he believed T cells should work for all tumor types. This was before he won the Nobel prize. Completely agree with him and met him for the first time at the Nixon / Milken Institute, Cancer 2035: A Roadmap for the Future. This conversation was a great prelude to my presentation on T and NK cells. From taking off the brakes of T cells to growing T cells and NK cells.

youtube.com/live/DKd8YPX3g…

03/20/2026

So here we are in 2026 and I was so excited to hear Jim's comment just before I gave my talk,

"...the field has changed a bit and it was all about taking the brakes off T cells now its understanding how T cells are modulated by all the other different components of the immune system so its a lot more complex..."

That was exactly our focus and trials over the last decade to identify the killers and the suppressors in the tumor microenvironment and orchestrate our treatment based on the dynamics of "quantum" oncotherapeutics - how NK cells and T cells modulate each other.

youtube.com/live/DKd8YPX3g…

03/20/2026

My talk on Feb 24 at the 55th anniversary of President Nixon's war on cancer. Deconstructing the mind map for the first time in ten years.

A good prelude to the discussion at the annual update on March 3 at 1:30pm ET. To listen to the update, the link is below. immunitybio.com/immunitybio-to…

The inertia despite new leadership. As reported in the Senate Aging hearing by Straight Arrow News (SAN):"But several ph...
03/20/2026

The inertia despite new leadership. As reported in the Senate Aging hearing by Straight Arrow News (SAN):

"But several physicians and experts told SAN that the FDA’s unpredictability predated the current FDA leadership."

“I started dealing with the FDA committee in 2023. When I talked in my testimony about talking to a brick wall, that was the last administration,” said Schmahmann. “The FDA seems to be carving their own path, regardless of who’s in Congress or the White House.

03/20/2026

Love the animation! Killing the tumor from the outside in and releasing the antigens. Special forces

Address

Log Angeles
Los Angeles, CA
92804

Opening Hours

Monday 7:30am - 5pm
Tuesday 7:30am - 5pm
Wednesday 7:30am - 5pm
Thursday 7:30am - 5pm
Friday 7:30am - 5pm
Saturday 7:30am - 3pm

Website

Alerts

Be the first to know and let us send you an email when dr Patrick soon shiong posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category